⌘K

Login Start Free

Home/Filings/4/0001312326-18-000002

4//SEC Filing

Baxter Nicholas W 4

Accession 0001312326-18-000002

CIK 0001348362other

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 3:06 PM ET

Size

6.3 KB

Accession

0001312326-18-000002

Insider Transaction Report

Form 4

Period: 2015-12-16

Lexaria Bioscience Corp.LXRP

Baxter Nicholas W

Director

Transactions

Purchase
Options
2018-05-31+50,000→ 160,000 total
Exercise: $1.53From: 2023-05-31Exp: 2023-05-31→ Lexaria Common Shares (50,000 underlying)

Holdings

Options
Exercise: $0.10From: 2019-12-23Exp: 2019-12-23→ Lexaria Common Shares (110,000 underlying)
110,000

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001312326

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 3:06 PM ET
Size: 6.3 KB

View on SEC.gov